» Articles » PMID: 35740027

Extracellular Signal-Regulated Kinase 1 Alone Is Dispensable for Hyperoxia-Mediated Alveolar and Pulmonary Vascular Simplification in Neonatal Mice

Overview
Date 2022 Jun 24
PMID 35740027
Authors
Affiliations
Soon will be listed here.
Abstract

Bronchopulmonary dysplasia (BPD) is a morbid lung disease distinguished by lung alveolar and vascular simplification. Hyperoxia, an important BPD causative factor, increases extracellular signal-regulated kinases (ERK)-1/2 expression, whereas decreased lung endothelial cell expression reduces angiogenesis and potentiates hyperoxia-mediated BPD in mice. However, ERK1's role in experimental BPD is unclear. Thus, we hypothesized that hyperoxia-induced experimental BPD would be more severe in global -knockout () mice than their wild-type ( mice) littermates. We determined the extent of lung development, ERK1/2 expression, inflammation, and oxidative stress in and mice exposed to normoxia (FiO 21%) or hyperoxia (FiO 70%). We also quantified the extent of angiogenesis and hydrogen peroxide (HO) production in hyperoxia-exposed neonatal human pulmonary microvascular endothelial cells (HPMECs) with normal and decreased signaling. Compared with mice, mice displayed increased pulmonary ERK2 activation upon hyperoxia exposure. However, the extent of hyperoxia-induced inflammation, oxidative stress, and interrupted lung development was similar in and mice. knockdown in HPMECs increased ERK2 activation at baseline, but did not affect in vitro angiogenesis and hyperoxia-induced HO production. Thus, we conclude is dispensable for hyperoxia-induced experimental BPD due to compensatory ERK2 activation.

Citing Articles

Research progress of microvascular development in bronchopulmonary dysplasia.

Zhang J, Du W, Zhang Z, Li T, Li X, Xi S Pediatr Investig. 2024; 8(4):299-312.

PMID: 39720284 PMC: 11664543. DOI: 10.1002/ped4.12441.


Amphiregulin Exerts Proangiogenic Effects in Developing Murine Lungs.

Thapa S, Shankar N, Shrestha A, Civunigunta M, Gaikwad A, Shivanna B Antioxidants (Basel). 2024; 13(1).

PMID: 38247502 PMC: 10812697. DOI: 10.3390/antiox13010078.


Carbon dioxide and MAPK signalling: towards therapy for inflammation.

Galganska H, Jarmuszkiewicz W, Galganski L Cell Commun Signal. 2023; 21(1):280.

PMID: 37817178 PMC: 10566067. DOI: 10.1186/s12964-023-01306-x.


Hyperoxia Disrupts Lung Lymphatic Homeostasis in Neonatal Mice.

Shankar N, Thapa S, Shrestha A, Sarkar P, Gaber M, Barrios R Antioxidants (Basel). 2023; 12(3).

PMID: 36978868 PMC: 10045755. DOI: 10.3390/antiox12030620.


Molecular mechanisms of cell death in bronchopulmonary dysplasia.

Deng X, Bao Z, Yang X, Mei Y, Zhou Q, Chen A Apoptosis. 2022; 28(1-2):39-54.

PMID: 36369365 DOI: 10.1007/s10495-022-01791-4.

References
1.
Bhandari V . Hyperoxia-derived lung damage in preterm infants. Semin Fetal Neonatal Med. 2010; 15(4):223-9. PMC: 2910132. DOI: 10.1016/j.siny.2010.03.009. View

2.
Arnaoutova I, Kleinman H . In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract. Nat Protoc. 2010; 5(4):628-35. DOI: 10.1038/nprot.2010.6. View

3.
Lapcharoensap W, Bennett M, Xu X, Lee H, Dukhovny D . Hospitalization costs associated with bronchopulmonary dysplasia in the first year of life. J Perinatol. 2019; 40(1):130-137. PMC: 6920537. DOI: 10.1038/s41372-019-0548-x. View

4.
Reynolds C, Zhang S, Shrestha A, Barrios R, Shivanna B . Phenotypic assessment of pulmonary hypertension using high-resolution echocardiography is feasible in neonatal mice with experimental bronchopulmonary dysplasia and pulmonary hypertension: a step toward preventing chronic obstructive pulmonary.... Int J Chron Obstruct Pulmon Dis. 2016; 11:1597-605. PMC: 4951055. DOI: 10.2147/COPD.S109510. View

5.
Sehgal A, Gwini S, Menahem S, Allison B, Miller S, Polglase G . Preterm growth restriction and bronchopulmonary dysplasia: the vascular hypothesis and related physiology. J Physiol. 2018; 597(4):1209-1220. PMC: 6376075. DOI: 10.1113/JP276040. View